| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 152.98M | 142.44M | 147.33M | 52.10M | 101.10M | 62.02M |
| Gross Profit | 48.46M | 83.50M | 92.46M | 23.17M | 84.93M | 48.60M |
| EBITDA | 37.29M | 74.74M | 84.11M | 16.50M | 87.28M | 55.40M |
| Net Income | 36.01M | 73.65M | 83.84M | 15.54M | 83.63M | 54.67M |
Balance Sheet | ||||||
| Total Assets | 1.63B | 1.66B | 1.63B | 1.30B | 1.32B | 1.05B |
| Cash, Cash Equivalents and Short-Term Investments | 5.79M | 10.13M | 7.78M | 6.40M | 10.07M | 1.90M |
| Total Debt | 875.32M | 875.84M | 844.78M | 654.46M | 631.04M | 471.93M |
| Total Liabilities | 913.55M | 915.64M | 884.78M | 690.34M | 665.52M | 494.15M |
| Stockholders Equity | 714.08M | 740.64M | 742.59M | 612.54M | 652.28M | 560.00M |
Cash Flow | ||||||
| Free Cash Flow | 37.09M | 82.75M | 61.81M | 58.38M | 28.45M | -61.80M |
| Operating Cash Flow | 37.09M | 82.75M | 61.81M | 58.38M | 28.45M | -61.80M |
| Investing Cash Flow | 12.09M | -23.85M | 30.48M | -30.43M | -186.11M | -106.30M |
| Financing Cash Flow | -58.66M | -43.47M | -84.99M | -34.41M | 166.32M | 63.22M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Neutral | $472.87M | 8.29 | 11.86% | 10.78% | 41.12% | -40.68% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | $555.84M | 5.63 | 18.68% | 10.76% | -45.46% | 134.73% | |
66 Neutral | $525.29M | 14.62 | 4.92% | 13.05% | -20.18% | -61.90% | |
58 Neutral | $509.05M | ― | -1.15% | 22.98% | -91.81% | 78.46% | |
58 Neutral | $500.69M | 19.15 | 3.22% | 15.11% | -11.01% | -65.56% | |
54 Neutral | $376.76M | 11.51 | 6.83% | 16.72% | -3.09% | 200.66% |
On October 30, 2025, Crescent Capital BDC, Inc. entered into a Fourth Supplement to Note Purchase Agreement with institutional investors for the issuance of $185 million in senior unsecured notes, due between 2029 and 2031. The proceeds from these notes are intended for repaying existing indebtedness and general corporate purposes, potentially impacting the company’s financial flexibility and investment capabilities.
The most recent analyst rating on (CCAP) stock is a Hold with a $15.50 price target. To see the full list of analyst forecasts on Crescent Capital BDC stock, see the CCAP Stock Forecast page.
Crescent Capital BDC, Inc. recently held its earnings call, where the sentiment was notably neutral. The company reported stable net investment income and strong dividend coverage, supported by a diversified portfolio. However, challenges such as a decrease in net asset value (NAV), an increased watch list, and constrained market conditions balanced out these positives.
Crescent Capital BDC, Inc. is a business development company focused on providing capital solutions to middle market companies, aiming to maximize total return for its stockholders through current income and capital appreciation.